-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

European Perspective: Hematopoietic Cell Transplant

Program: General Sessions
Session: ASH-EHA Joint Symposium: Failure of Targeted Cellular Immunotherapy and Hematopoietic Cell Transplant: Mechanisms and Mitigating Strategies
Sunday, December 6, 2020, 9:30 AM-10:30 AM

Luca Vago, MD, PhD

Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milano, Italy; Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy

Disclosures: Vago: GEN-DX: Patents & Royalties; Moderna Therapeutics: Consultancy, Research Funding.

See more of: ASH-EHA Joint Symposium: Failure of Targeted Cellular Immunotherapy and Hematopoietic Cell Transplant: Mechanisms and Mitigating Strategies
See more of: General Sessions
<< Previous Presentation | Next Presentation